Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Australia is highly cost-competitive for early-phase clinical trials compared to the U.S. It is 28% cheaper than the U.S. before tax incentives and 60% after tax incentives. The country has a simplified regulatory process for the approval of clinical trials.
It operates a Clinical Trial Notification scheme, which means that the regulator delegates the trial review process to ethics committees and only needs to be notified of the outcome. This, in turn, minimizes the regulatory burden on clinical trial sponsors, enabling them to save time & money.
The Australian government is also implementing reforms to reduce study start-up times, boost patient recruitment, and standardize clinical trial costs. The Department of Health and industry stakeholders are working together to improve clinical research and trial environment in Australia.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Australia bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account